Continuous TQL Block for Elective Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

April 8, 2020

Study Completion Date

April 8, 2020

Conditions
Postoperative PainAnesthesia, Local
Interventions
DRUG

Ropivacaine

2 x 30 ml ropivacaine 0,2% and an elastomere pump with 200 ml ropivacaine 0,2%, infusion rate 8 ml/hour

DRUG

Saline

2 x 30 mL isotonic saline and an elastomere pump with 200 ml isotonic saline, infusion rate 8 ml/hour

Trial Locations (1)

4000

Department of anaesthesiology, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT03663478 - Continuous TQL Block for Elective Cesarean Section | Biotech Hunter | Biotech Hunter